Wells Fargo Reaffirms Their Hold Rating on Crescent Capital BDC (CCAP)
Crescent Capital BDC Is Maintained at Outperform by Keefe, Bruyette & Woods
Crescent Capital BDC Analyst Ratings
KBW Maintains Crescent Capital BDC(CCAP.US) With Buy Rating, Raises Target Price to $20
Ladenburg Thalmann Initiates Crescent Capital BDC(CCAP.US) With Buy Rating, Announces Target Price $20
Crescent Capital BDC Analyst Ratings
B of A Securities Maintains Buy on Crescent Capital BDC, Lowers Price Target to $19
BofA Securities Maintains Crescent Capital BDC(CCAP.US) With Buy Rating, Raises Target Price to $19
Crescent Capital BDC: A Buy Rating Backed by Strong Performance and Resilient Credit Portfolio
KBW Maintains Crescent Capital BDC(CCAP.US) With Buy Rating, Maintains Target Price $19
Crescent Capital BDC Analyst Ratings
Wells Fargo Maintains Crescent Capital BDC(CCAP.US) With Hold Rating, Cuts Target Price to $18
KBW Maintains Crescent Capital BDC(CCAP.US) With Buy Rating, Maintains Target Price $19
KBW Sticks to Its Buy Rating for Crescent Capital BDC (CCAP)
Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Raises Price Target to $19
Crescent Capital BDC Analyst Ratings
Wells Fargo Maintains Crescent Capital BDC(CCAP.US) With Hold Rating, Raises Target Price to $19
Wells Fargo Remains a Hold on Crescent Capital BDC (CCAP)
Crescent Capital BDC Analyst Ratings
Crescent Capital BDC Inc: KBW raises target price from $19 to $18.5